Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

0.9750 +0.0450 (+4.84%)
Streaming Delayed Price Updated: 10:05 AM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
6 Analysts Have This to Say About Adicet Bio
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
 
Via Benzinga
US Stocks Higher; Durable Goods Orders Top Estimates
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 75 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.19% to 33,780.40 while the NASDAQ rose... 
Via Benzinga
Adicet Bio's Cancer Candidate Shows Anti-Tumor Activity In Preclinical Study
Adicet Bio Inc (NASDAQ: ACET)  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Adicet Bio Stock Is Falling Premarket - Here's Why
Adicet Bio Inc (NASDAQ: ACET) shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning! 
Via InvestorPlace
MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
From Adicet Bio, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 64 companies achieved new lows for the year. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
 
Via Benzinga
Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
Via InvestorPlace
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
7 Biotech Stocks That Could Be the Next Big Thing
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough. 
Via InvestorPlace
Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 35 stocks hit new 52-week lows. 
Via Benzinga
Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 16 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.